Analysts Issue Forecasts for RLI’s Q2 Earnings (NYSE:RLI)

RLI Corp. (NYSE:RLIFree Report) – Equities research analysts at Zacks Research cut their Q2 2026 earnings per share estimates for RLI in a research report issued to clients and investors on Wednesday, March 18th. Zacks Research analyst Team now expects that the insurance provider will post earnings of $0.68 per share for the quarter, down from their prior forecast of $0.74. Zacks Research currently has a “Strong Sell” rating on the stock. The consensus estimate for RLI’s current full-year earnings is $3.08 per share. Zacks Research also issued estimates for RLI’s FY2026 earnings at $2.72 EPS, Q1 2027 earnings at $0.80 EPS, Q2 2027 earnings at $0.67 EPS and Q3 2027 earnings at $0.62 EPS.

Other research analysts also recently issued research reports about the company. Truist Financial set a $58.00 price objective on RLI in a report on Friday, January 23rd. Keefe, Bruyette & Woods raised RLI from a “moderate buy” rating to a “strong-buy” rating in a research note on Tuesday, February 24th. Citizens Jmp reiterated a “market perform” rating on shares of RLI in a research report on Friday, January 23rd. Wells Fargo & Company set a $59.00 target price on shares of RLI and gave the company an “equal weight” rating in a research report on Friday, January 23rd. Finally, Jefferies Financial Group upgraded shares of RLI from an “underperform” rating to a “hold” rating and set a $52.00 price target for the company in a research report on Friday, January 23rd. One analyst has rated the stock with a Strong Buy rating, six have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $65.20.

Check Out Our Latest Research Report on RLI

RLI Price Performance

RLI opened at $58.06 on Friday. The stock has a market capitalization of $5.34 billion, a P/E ratio of 13.32 and a beta of 0.50. The company’s 50 day simple moving average is $60.38 and its 200-day simple moving average is $62.44. RLI has a one year low of $55.80 and a one year high of $81.79.

RLI (NYSE:RLIGet Free Report) last posted its quarterly earnings data on Wednesday, January 21st. The insurance provider reported $0.94 earnings per share for the quarter, beating the consensus estimate of $0.76 by $0.18. RLI had a net margin of 21.43% and a return on equity of 18.67%. The firm had revenue of $465.69 million during the quarter, compared to analysts’ expectations of $447.53 million. During the same quarter last year, the company posted $0.41 EPS.

RLI Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Monday, March 16th. Shareholders of record on Monday, March 2nd were issued a dividend of $0.16 per share. The ex-dividend date was Monday, March 2nd. This represents a $0.64 annualized dividend and a yield of 1.1%. RLI’s payout ratio is currently 14.68%.

Insider Transactions at RLI

In other RLI news, CEO Craig W. Kliethermes purchased 5,000 shares of the company’s stock in a transaction dated Friday, January 23rd. The shares were bought at an average price of $57.45 per share, with a total value of $287,250.00. Following the completion of the transaction, the chief executive officer directly owned 143,990 shares in the company, valued at $8,272,225.50. This trade represents a 3.60% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, COO Jennifer L. Klobnak acquired 2,000 shares of the firm’s stock in a transaction that occurred on Friday, January 23rd. The stock was acquired at an average price of $57.99 per share, with a total value of $115,980.00. Following the completion of the transaction, the chief operating officer directly owned 100,318 shares in the company, valued at $5,817,440.82. This trade represents a 2.03% increase in their position. The disclosure for this purchase is available in the SEC filing. 2.16% of the stock is currently owned by insiders.

Institutional Investors Weigh In On RLI

A number of hedge funds and other institutional investors have recently made changes to their positions in RLI. Chatham Capital Group Inc. lifted its position in RLI by 0.7% in the 4th quarter. Chatham Capital Group Inc. now owns 26,460 shares of the insurance provider’s stock valued at $1,693,000 after acquiring an additional 180 shares in the last quarter. Covestor Ltd increased its holdings in RLI by 13.0% during the 4th quarter. Covestor Ltd now owns 1,590 shares of the insurance provider’s stock worth $102,000 after purchasing an additional 183 shares in the last quarter. Allworth Financial LP raised its stake in shares of RLI by 5.3% in the 3rd quarter. Allworth Financial LP now owns 3,760 shares of the insurance provider’s stock valued at $245,000 after purchasing an additional 189 shares during the period. Farther Finance Advisors LLC grew its holdings in shares of RLI by 94.4% during the fourth quarter. Farther Finance Advisors LLC now owns 414 shares of the insurance provider’s stock worth $26,000 after buying an additional 201 shares in the last quarter. Finally, Public Employees Retirement System of Ohio lifted its stake in RLI by 0.3% in the 3rd quarter. Public Employees Retirement System of Ohio now owns 75,502 shares of the insurance provider’s stock valued at $4,924,000 after acquiring an additional 207 shares in the last quarter. 77.89% of the stock is currently owned by institutional investors and hedge funds.

About RLI

(Get Free Report)

RLI Corporation (NYSE:RLI) is a specialty property and casualty insurance company focused on underwriting niche risks for businesses and individuals. Headquartered in Peoria, Illinois, the company operates through a network of independent agents and brokers, offering customized coverage solutions. RLI’s approach emphasizes disciplined underwriting, targeted product development and strong customer service to maintain profitability and long-term growth.

Founded in 1965 as Replacement Lens, Inc, RLI initially provided insurance for contact lens manufacturers before shifting its focus to specialty insurance in the 1980s.

Featured Stories

Earnings History and Estimates for RLI (NYSE:RLI)

Receive News & Ratings for RLI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RLI and related companies with MarketBeat.com's FREE daily email newsletter.